Who is eligible for clinical trial NCT06967545?

Participants must meet protocol criteria for Suicide Attempt. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT06967545 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-07-08

A One-Arm Open Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior (NCT06967545)

🟢 Recruiting Observational / Diagnostic 🧠 Behavioral & Psychological Program Sponsor: Massachusetts General Hospital

🩺 Plain-English Summary (8th-Grade Level)

This study aims to evaluate the acceptability, safety, and preliminary efficacy of a smartphone-delivered intervention called Therapeutic Evaluative Conditioning for Suicide (TEC-S) in reducing suicidal thoughts and behaviors (STB) among adults with recent and frequent suicide ideation.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (7 items) and avoid the listed exclusions (6 items).

Location: Massachusetts General Hospital — Boston, Massachusetts

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Adults ages 18+
Relatively frequent and recent (≥5 days within the past-month) active suicidal thoughts as assessed via SITBI-R.
Willing and able to provide at least one emergency contact (name, phone number, relation).
Owns an Android or iOS smartphone.
Possesses at least occasional access to Wi-Fi-enabled internet for data down/uploads.
Fluent in English and willing to provide informed consent.
Living in the Boston metropolitan area (i.e., \~50 mile radius around Boston, MA)

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Recent (past 3-month) hypo/manic symptoms or homicidal ideation or lifetime psychosis spectrum diagnosis as assessed via MINI 7.0.2.
Recent acute suicide risk operationalized as affirmative responses to BOTH below items during structured clinical interview AND evaluation by the PI in consultation with Mentors/Advisor Drs. Wilhelm, Kleiman, and/or Bentley:
At any time in past week: ≥ 8/10 current intent to act on suicidal thoughts (0 \["not at all"\] to 10 \["extremely strong"\]); AND
At any time in past week: thought of a specific suicide plan (i.e, known method/means and/or location) with access to lethal means
Impaired vision (e.g., legal blindness), technological illiteracy, or intellectual disability that might impair ability to provide valid data and/or informed consent.

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

Massachusetts General Hospital — Boston, Massachusetts

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗